SCR-LIP-000302 · Claim · machine-readable JSON →

This narrative review synthesizes lipedema pathophysiology as a self-perpetuating cycle of adipocyte hypertrophy, dense interstitial fibrosis, lymphatic microangiopathy, and chronic low-grade inflammation, with M1 macrophage accumulation secreting TNF-alpha, IL-6, and MCP-1 and elevated fibrotic marker YKL-40, plus estrogen-axis dysregulation (ERbeta predominance, local estradiol excess) and mitochondrial dysfunction (reduced oxidative capacity, UCP1 downregulation).

Emerging clinical association Evidence certainty: very low (GRADE)

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2025DOI:10.3390/ijms262110741 · supporting

Evidence (1)

Context (PECO)

Conditionlipedema
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log